GlassScriptPhysician profile
Michael L Potruch
NPI 1013977768
$1,923.49
in general payments reported to CMS, 2019-2025
14 companies · $794 in 2025
The $794 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $37.95 · 2021: $41.28 · 2022: $95.38 · 2023: $32.51 · 2024: $922 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,400 · Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,400.00 |
| Food and Beverage | $348.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,400.00 | 2024-2025 | |
| Abbvie INC. | $92.69 | 2020-2022 | |
| Astellas Pharma US INC | $89.05 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $60.52 | 2022-2025 | |
| Organon LLC | $54.70 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $46.34 | 2022-2023 | Coolseal Generator, Acessa Provu System |
| Millicent US INC | $40.80 | 2025 | Femlyv, Intrarosa |
| Sage Therapeutics, LLC | $31.21 | 2025 | Zurzuvae |
| Meditrina | $24.37 | 2024 | |
| Exeltis, USA INC. | $22.12 | 2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $20.27 | 2025 | |
| Pfizer INC. | $17.17 | 2025 | |
| Janssen Pharmaceuticals, INC | $15.05 | 2020 | |
| Channel Medsystems, INC. | $9.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Potruch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.